Ypsomed Holding AG (FRA:OWX) EBIT : €83.7 Mil (TTM As of Sep. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG EBIT?

Ypsomed Holding AG's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2023 was €42.1 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was €83.7 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ypsomed Holding AG's annualized ROC % for the quarter that ended in Sep. 2023 was 8.34%. Ypsomed Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 19.49%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ypsomed Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 1.61%.

Ypsomed Holding AG EBIT Historical Data

The historical data trend for Ypsomed Holding AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG EBIT Chart

Ypsomed Holding AG Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EBIT

Get a 7-Day Free Trial

62.34

8.15

7.08

26.96

59.26

Ypsomed Holding AG Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EBIT	Get a 7-Day Free Trial															8.82	17.60	18.19	41.57	42.09

Competitive Comparison of Ypsomed Holding AG's EBIT

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ypsomed Holding AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's EV-to-EBIT falls into.

Ypsomed Holding AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €83.7 Mil.

Ypsomed Holding AG (FRA:OWX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ypsomed Holding AG's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

	ROC % (Q: Sep. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2023 )	+	Invested Capital (Q: Sep. 2023 ))	/ count )
=	83.09 * ( 1 - 4.4% )	/	( (890.687	+	1014.466)	/ 2 )
=	79.43404	/	952.5765
=	8.34 %

where

	Invested Capital		(Q: Mar. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	869.795	-	30.235	-	( 25.456	-	max(0, 261.367	-	210.24	+	25.456	))
=	890.687

	Invested Capital		(Q: Sep. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	975.625	-	37.22	-	( 37.891	-	max(0, 335.676	-	259.615	+	37.891	))
=	1014.466

Note: The Operating Income data used here is two times the semi-annual (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Ypsomed Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2023		Q: Sep. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	84.18	/	( ( (383.073 + max(66.668, 0))	+	(414.301 + max(-130.444, 0)) )	/	2 )
=	84.18	/	( ( 449.741	+	414.301 )	/	2 )
=	84.18	/	432.021
=	19.49 %

where Working Capital is:

	Working Capital		(Q: Mar. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(94.193	+	58.234	+	17.166)	-	(30.235	+	0	+	72.69)
=	66.668

	Working Capital		(Q: Sep. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(99.669	+	72.396	+	33.167)	-	(37.22	+	0	+	298.456)
=	-130.444

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ypsomed Holding AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2023 )
	=	83.661	/	5200.517
	=	1.61 %

Ypsomed Holding AG EBIT Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ypsomed Holding AG (FRA:OWX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (FRA:OWX) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

YPSNz:UK YPSN:Switzerland

Address

Brunnmattstrasse 6, Burgdorf, CHE, 3401

Website

https://www.ypsomed.com

Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (FRA:OWX) Headlines

No Headlines